NCT04642391View on ClinicalTrials.gov

Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

August 2, 2021

Primary Completion Date

June 30, 2023

Study Completion Date

June 30, 2024

Conditions
CirrhosisAdrenal Insufficiency
Interventions
DRUG

Cosyntropin

Administer 0.25mg Cosyntropin to determine adrenal sufficiency vs. insufficiency in patients with decompensated cirrhosis

Trial Locations (1)

22903

University of Virginia Health System, Charlottesville

All Listed Sponsors
collaborator

American Association for the Study of Liver Diseases

OTHER

lead

University of Virginia

OTHER

NCT04642391 - Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis | Biotech Hunter | Biotech Hunter